Nadyrshina, D.,
Zaripova, A.,
Tyurin, A.,
Minniakhmetov, I.,
Zakharova, E.,
Khusainova, R. (2022) found
combined mutations (c.2869C>T, p. Gln957* in COL1A1 and c.1197+5G>A in COL1A2; c.579delT, p. Gly
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) studying subpopulations of lymphocytes, depending on the
combined pathology, we found that the absolute
Parfenova, Lyudmila V.,
Galimshina, Zulfiya R.,
Gil’fanova, Guzel U.,
Alibaeva, Eliza I.,
Danilko, Ksenia V.,
Aubakirova, Veta R.,
Farrakhov, Ruzil G.,
Parfenov, Evgeny V.,
Valiev, Ruslan Z. (2022) activity of the titanium surface by creating coatings that
combine both an inorganic phase with a given
Ganeev, T.,
Kabirova, M.,
Averyanov, S.,
Kamilov, F.,
Kozlov, V.,
Farshatova, E.,
Yunusov, R.,
Ponomarev, E. (2022) . The necessity of developing a complex of therapeutic and preventive measures of dental
care,
combinedDobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) weight of more than 6% since the start of APs
therapy. Group 2 comprised 74 patients with SSDs taking APs
be used for diagnosis and prognosis, including the response of a particular patient to
therapy the sensitivity of glioblastoma to current
therapies. © 2022 The Authors
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to
therapy. Modern